Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clingen Thrombosis Variant Curation Expert Panel, |
RCV002085194 | SCV005442760 | uncertain significance | Hereditary antithrombin deficiency | 2024-10-02 | reviewed by expert panel | curation | The c.1278G>A (NM_000488.4) variant in SERPINC1 does not code for a different amino acid (p.Ser426=). SpliceAI predicts no splicing impact for this variant which suggests that the variant does not impact SERPINC1 function (BP4). In summary, based on the evidence available at this time, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the Thrombosis Variant Curation Expert Panel for SERPINC1: BP4. |
Labcorp Genetics |
RCV002085194 | SCV002373469 | likely benign | Hereditary antithrombin deficiency | 2021-07-03 | criteria provided, single submitter | clinical testing |